CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 402,067,000 | 372,809,000 | 357,776,000 | 322,467,000 | 292,111,000 |
| Cost of Goods | 221,167,000 | 206,287,000 | 217,098,000 | 196,892,000 | 175,803,000 |
| Gross Profit | 180,900,000 | 166,522,000 | 140,678,000 | 125,575,000 | 116,308,000 |
| Operating Expenses | 176,240,000 | 158,006,000 | 126,935,000 | 117,621,000 | 102,998,000 |
| Operating Income | 4,660,000 | 8,516,000 | 13,743,000 | 7,954,000 | 13,310,000 |
| Interest Expense | 3,119,000 | 2,958,000 | 2,658,000 | 2,287,000 | 2,503,000 |
| Other Income | 595,000 | 590,000 | 88,000 | 169,000 | -270,000 |
| Pre-tax Income | 2,136,000 | 6,148,000 | 11,173,000 | 5,836,000 | 10,537,000 |
| Income Tax | 408,000 | 1,562,000 | 2,805,000 | 1,509,000 | 2,548,000 |
| Net Income Continuous | 1,728,000 | 4,586,000 | 8,368,000 | 4,327,000 | 7,989,000 |
| Minority Interests | -40,000 | -28,000 | 24,000 | 16,000 | -12,000 |
| Net Income | $1,768,000 | $4,614,000 | $8,344,000 | $4,311,000 | $8,001,000 |
| EPS Basic Total Ops | 1.40 | 3.67 | 6.49 | 3.29 | 6.07 |
| EPS Basic Continuous Ops | 1.36 | 3.64 | 6.51 | 3.30 | 6.06 |
| EPS Diluted Total Ops | 1.39 | 3.66 | 6.47 | 3.26 | 6.02 |
| EPS Diluted Continuous Ops | 1.36 | 3.63 | 6.49 | 3.27 | 6.01 |
| EPS Diluted Before Non-Recurring Items | N/A | 5.42 | 8.74 | 8.69 | 8.40 |
| EBITDA(a) | $14,991,000 | $13,113,000 | $18,109,000 | $12,178,000 | $18,227,000 |